Suspension Of China Drug Track And Trace Platform Prompts Spat
This article was originally published in SRA
Executive Summary
The China Food and Drug Administration is inviting feedback on how to change the way it monitors drugs in the supply chain after temporarily suspending its electronic system for monitoring and tracking drug products (Drug PIATS), which is operated by Hong Kong-listed Alibaba Health Information Technology.